Background Chlorella species have attracted attention for their potential to improve cardiovascular and metabolic health; however, comprehensive evidence from controlled trials remains limited. Methods A comprehensive search of PubMed, CENTRAL, Web of Science, Scopus, and EMBASE databases was conducted up to February 2025. Study quality and certainty of evidence were assessed using the Cochrane Risk of Bias and Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) tools, respectively. Results Thirty-three studies were included. Chlorella supplementation led to significant reductions in body fat (Weighted Mean Difference [WMD] = -0.72%; 95% Confidence Interval [CI]: -1.09, -0.35; P < 0.001), body mass index (WMD = -0.29 kg/m2; 95% CI:-0.44, -0.15; P < 0.001), weight (WMD = -1.52 kg; 95% CI:-2.07, -0.97; P < 0.001), waist-to-hip ratio (WMD = -0.01%; 95% CI:-0.01, -0.01; P < 0.001), homeostatic model assessment of insulin resistance (WMD = -0.20; 95% CI:-0.33, -0.08; P = 0.002), insulin (WMD = -0.97 µIU/mL; 95% CI:-1.38, -0.55; P < 0.001), low-density lipoprotein-cholesterol (WMD = -5.70 mg/dL; 95% CI:-8.10, -3.31; P < 0.001), total cholesterol (WMD = -7.02 mg/dL; 95% CI:-9.78, -4.25; P < 0.001), alanine transaminase (WMD = -4.84 IU/L; 95% CI:-6.46, -3.21; P < 0.001), aspartate aminotransferase (WMD = -3.38 IU/L; 95% CI:-4.65, -2.11; P < 0.001), and lactate dehydrogenase (WMD = -14.13 U/L; 95% CI: -25.18 to -3.09; P = 0.012). Additionally, there were significant increases in high-density lipoprotein-cholesterol (WMD = 1.57 mg/dL; 95% CI:0.27, 2.87; P = 0.018). Conclusions Chlorella supplementation demonstrates meaningful benefits for cardiometabolic health, with effects influenced by species, dosage, and participant characteristics. While this analysis has some limitations, further long-term studies are required to optimize its clinical application. Overall, Chlorella appears to be a promising supplement that may warrant inclusion in dietary interventions. Graphical Abstract

Chlorella for health: evidence from a GRADE-assessed systematic review and dose–response meta-analysis

期刊论文
出版模式：

开放获取
发表日期：

2026年7月29日

查看全文

Ali Jafari,
Helia Mardani,
Niloufar Rasaei,
Bahare Parsi Nezhad,
Amirhossein Sahebkar

摘要

Background

Chlorella species have attracted attention for their potential to improve cardiovascular and metabolic health; however, comprehensive evidence from controlled trials remains limited.

Methods

A comprehensive search of PubMed, CENTRAL, Web of Science, Scopus, and EMBASE databases was conducted up to February 2025. Study quality and certainty of evidence were assessed using the Cochrane Risk of Bias and Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) tools, respectively.

Results

Thirty-three studies were included. Chlorella supplementation led to significant reductions in body fat (Weighted Mean Difference [WMD] = -0.72%; 95% Confidence Interval [CI]: -1.09, -0.35; P < 0.001), body mass index (WMD = -0.29 kg/m²; 95% CI:-0.44, -0.15; P < 0.001), weight (WMD = -1.52 kg; 95% CI:-2.07, -0.97; P < 0.001), waist-to-hip ratio (WMD = -0.01%; 95% CI:-0.01, -0.01; P < 0.001), homeostatic model assessment of insulin resistance (WMD = -0.20; 95% CI:-0.33, -0.08; P = 0.002), insulin (WMD = -0.97 µIU/mL; 95% CI:-1.38, -0.55; P < 0.001), low-density lipoprotein-cholesterol (WMD = -5.70 mg/dL; 95% CI:-8.10, -3.31; P < 0.001), total cholesterol (WMD = -7.02 mg/dL; 95% CI:-9.78, -4.25; P < 0.001), alanine transaminase (WMD = -4.84 IU/L; 95% CI:-6.46, -3.21; P < 0.001), aspartate aminotransferase (WMD = -3.38 IU/L; 95% CI:-4.65, -2.11; P < 0.001), and lactate dehydrogenase (WMD = -14.13 U/L; 95% CI: -25.18 to -3.09; P = 0.012). Additionally, there were significant increases in high-density lipoprotein-cholesterol (WMD = 1.57 mg/dL; 95% CI:0.27, 2.87; P = 0.018).

Conclusions

Chlorella supplementation demonstrates meaningful benefits for cardiometabolic health, with effects influenced by species, dosage, and participant characteristics. While this analysis has some limitations, further long-term studies are required to optimize its clinical application. Overall, Chlorella appears to be a promising supplement that may warrant inclusion in dietary interventions.

Graphical Abstract